CalciMedica, Inc.
CalciMedica, Inc. (CALC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CALC · as of Sep 30, 2025
Ownership Breakdown
31
Institutional Holders
▲ 1 vs Q2
$10.95M
Total Inst. Value
▲ $5.02M vs Q2
15.80M
Shares Outstanding
freeFloat 56.57%
3.57M
13F Shares Held
▼ 157,350 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CALC largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ENVESTNET ASSET MANAGEMENT INC pharmaceutical preparations | 76.7K | 51.15% | 51.15% | $235.93M | Nov 5, 2025 | ▼ 16.7K |
MERITAGE PORTFOLIO MANAGEMENT pharmaceutical preparations | 61.5K | 41.04% | 41.04% | $189.28M | Oct 28, 2025 | ▲ 15.5K |
STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD pharmaceutical preparations | 53.7K | 35.81% | 35.81% | $165.18M | Nov 3, 2025 | NEW |
SHEETS SMITH INVESTMENT MANAGEMENT pharmaceutical preparations | 51.1K | 34.08% | 34.08% | $157.17M | Oct 8, 2025 | NEW |
180 WEALTH ADVISORS, LLC pharmaceutical preparations | 42.7K | 28.48% | 28.48% | $131.34M | Oct 16, 2025 | ▼ 7.8K |
TRITONPOINT WEALTH, LLC pharmaceutical preparations | 15.1K | 10.08% | 10.08% | $46.50M | Oct 15, 2025 | — held |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 1.30M | 0.87% | 0.87% | $4.00B | Nov 14, 2025 | — held |
SOLEUS CAPITAL MANAGEMENT, L.P. pharmaceutical preparations | 683.9K | 0.46% | 0.46% | $2.10B | Nov 14, 2025 | ▼ 100.0K |
AISLING CAPITAL MANAGEMENT LP pharmaceutical preparations | 521.1K | 0.35% | 0.35% | $1.60B | Nov 12, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 376.6K | 0.25% | 0.25% | $1.14B | Nov 7, 2025 | ▲ 37.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
5
Increased
+88.8K shares7
New Positions
first time holders10
Decreased
−181.8K shares6
Sold Out
fully exitedNet shares change (top 50)
93.0K
+88.8K / −181.8K
Net new holders
-4
7 new / 6 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CALC insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Bardin Stephen Chief Financial Officer | Apr 5, 2025 | Award | 67,728 | $0.58 | $39.6K | 67.7K | Form 4 ↗ |
Hebbar Sudarshan Chief Medical Officer | Apr 5, 2025 | Award | 91,173 | $0.58 | $53.3K | 91.2K | Form 4 ↗ |
Roberts Eric W CHIEF BUSINESS OFFICER | Apr 5, 2025 | Award | 83,358 | $0.58 | $48.8K | 83.4K | Form 4 ↗ |
Dunn Michael J. President and COO | Apr 5, 2025 | Award | 65,124 | $0.58 | $38.1K | 65.1K | Form 4 ↗ |
Stauderman Kenneth A. Chief Scientific Officer | Apr 5, 2025 | Award | 65,124 | $0.58 | $38.1K | 65.1K | Form 4 ↗ |
Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Apr 5, 2025 | Award | 148,482 | $0.58 | $86.9K | 148.5K | Form 4 ↗ |
Glicklich Alan director | Oct 13, 2025 | Award | 937 | $3.26 | $3.1K | 937 | Form 4 ↗ |
Roberts Eric W CHIEF BUSINESS OFFICER | Sep 18, 2025 | Purchase | 2,500 | $3.07 | $7.7K | 84.2K | Form 4 ↗ |
Roberts Eric W CHIEF BUSINESS OFFICER | Sep 15, 2025 | Purchase | 3,400 | $2.68 | $9.1K | 81.7K | Form 4 ↗ |
Roberts Eric W CHIEF BUSINESS OFFICER | Sep 12, 2025 | Purchase | 5,000 | $3.12 | $15.6K | 78.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CalciMedica, Inc. (CALC) is primarily owned by institutional investors, who hold approximately 22.6% of total shares outstanding. Company insiders own approximately 43.43%, while retail and public investors account for the remaining 33.98%.
The largest institutional shareholder of CalciMedica, Inc. is ENVESTNET ASSET MANAGEMENT INC, holding approximately 76,705 shares — equal to 51.15% of outstanding shares — as of September 30, 2025.
A total of 31 institutional investors currently hold CALC stock, with a combined institutional value of approximately $10,948,007 as of the most recent 13F filing period.
Frequently asked questions
CALC ownershipCalciMedica, Inc. (CALC) is primarily owned by institutional investors, who hold approximately 22.6% of shares. The largest shareholder is ENVESTNET ASSET MANAGEMENT INC with a 51.15% stake. Company insiders hold 43.43%. Data sourced from SEC Form 13F as of September 30, 2025.